Abbott Laboratories vs. Zai Lab Limited American Depositary Shares
ABT
Abbott Laboratories
$111.25 -0.02%
VS ZLABZai Lab Limited American Depositary Shares
$25.90 -0.50%
Abbott Laboratories (ABT) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| ABT | ZLAB | |
|---|---|---|
| Market Cap | $191.92 billion | $2.86 billion |
| Revenue (TTM) | $46.59 billion | $449.61 million |
| Net Income (TTM) | $5.42 billion | $-188,213,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | ZLAB | |
|---|---|---|
| P/E Ratio | 36.00 | — |
| Price / Book | 3.71 | 4.71 |
| Price / Sales | 4.12 | 6.36 |
ABT leads on 2 of 2 valuation factors.
Profitability
| ABT | ZLAB | |
|---|---|---|
| Net Margin | 11.65% | -41.86% |
| Return on Equity | 10.48% | -31.01% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | ZLAB | |
|---|---|---|
| Dividend Yield | 2.27% | — |
| Payout Ratio | 81.55 | — |
ABT and ZLAB split the dividend factors evenly.
Risk & Sentiment
| ABT | ZLAB | |
|---|---|---|
| Short Interest | 0.57% | 1.02% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ZLAB overview, ZLAB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.